Swine Influenza

Swine influenza is a highly contagious acute respiratory disease of pigs caused by type A influenza viruses that regularly circulate in swine populations worldwide. The disease is characterized by sudden onset of clinical signs affecting large portions of a herd simultaneously, with rapid spread through susceptible populations followed by equally rapid recovery in most cases. Swine influenza virus (SIV) strains endemic in pig populations include H1N1, H1N2, and H3N2 subtypes, each maintaining characteristic circulation patterns in different geographic regions. The segmented nature of the influenza genome enables genetic reassortment when different strains co-infect the same host, generating novel variants that may escape existing immunity and occasionally produce strains with pandemic potential in human populations.

Swine influenza affects pigs of all ages, though clinical severity and presentation may vary across different age groups and immune statuses. Breeding animals exposed for the first time during gestation may experience reproductive losses including abortions and stillbirths, though this is less common than primary respiratory disease. Growing pigs typically experience the classic acute respiratory presentation with rapid onset and resolution. Nursery pigs facing their first exposure after maternal antibody waning may show more pronounced clinical signs than older animals with prior exposure history. Endemic circulation in many herds means that pigs often encounter swine influenza multiple times throughout their lives, with immunity from prior infections partially protecting against subsequent challenges with related strains.

The economic impact of swine influenza, while significant, typically falls short of the devastating losses associated with diseases like porcine reproductive and respiratory syndrome or porcine epidemic diarrhea. The self-limiting nature of uncomplicated influenza means that direct mortality is generally low. However, growth performance reductions during the acute illness phase, increased medication costs for secondary infection control, and potential reproductive losses in breeding herds contribute to economic burden. Secondary bacterial pneumonia following influenza-induced damage to respiratory defenses can substantially increase the morbidity and mortality associated with outbreaks. The cumulative economic impact across endemic herds represents significant annual losses to the global swine industry.

Effective swine influenza management requires understanding the dynamic nature of influenza virus epidemiology and the interplay between vaccination, natural infection, and population immunity. The continuous evolution of circulating strains through antigenic drift and reassortment creates ongoing challenges for vaccine development and strain matching. Strategic vaccination programs, combined with management practices that reduce transmission and support animal health, enable producers to minimize influenza impact. The zoonotic potential of swine influenza viruses adds public health dimensions to control efforts, requiring attention to biosecurity measures that protect both pig and human populations.

Swine influenza viruses are members of the family Orthomyxoviridae, genus Influenzavirus A, characterized by a segmented single-stranded RNA genome encoding for two surface glycoproteins that determine subtype classification. The hemagglutinin (H) protein mediates viral attachment and entry into host cells, while the neuraminidase (N) protein facilitates viral release from infected cells. Multiple H and N subtypes circulate in swine populations, with H1N1, H1N2, and H3N2 being the most prevalent globally. The segmented genome structure enables genetic reassortment when different influenza strains co-infect the same cell, shuffling gene segments to produce novel combinations. This capacity for rapid genetic change contributes to the emergence of new variants that may escape immunity developed against previous strains.

Genetic factors do not significantly influence swine influenza susceptibility at the breed level, as all domestic pig genetics remain fully susceptible to infection with influenza A viruses. Individual variation in immune response and disease severity exists but does not follow breed-specific patterns. Some research has explored genetic factors influencing influenza susceptibility and immune response, but no practical genetic selection programs for influenza resistance have been developed. The universal susceptibility of swine to influenza infection means that management and vaccination strategies rather than genetic selection form the foundation of control programs.

Environmental and management factors substantially influence swine influenza transmission dynamics and clinical outcomes. The virus spreads primarily through respiratory secretions via aerosol droplets expelled during coughing and sneezing. Direct nose-to-nose contact between infected and susceptible pigs enables efficient transmission. Cool, humid conditions favor viral survival in respiratory droplets and on contaminated surfaces. Seasonal patterns show increased influenza activity during fall and winter months in temperate climates, corresponding to conditions that enhance viral stability and transmission. High stocking densities accelerate spread within groups, with closed-confinement housing enabling rapid herd-wide transmission once virus is introduced.

Risk factors for swine influenza outbreaks include introduction of infected animals into naive populations, mixing of pigs from multiple sources with different immunity backgrounds, and environmental stressors that compromise respiratory defenses. Purchasing replacement breeding stock or feeder pigs from sources with active influenza circulation introduces virus directly into recipient herds. Commingling at marketing facilities or during transport creates mixing opportunities that generate novel reassortant strains. Temperature fluctuations, poor ventilation, and high ammonia levels compromise respiratory tract defenses and increase disease susceptibility. Concurrent infections with other respiratory pathogens including Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome virus worsen clinical outcomes.

The pathophysiology of swine influenza centers on viral tropism for respiratory epithelial cells lining the upper and lower airways. Following inhalation of infectious aerosol particles, the virus attaches to sialic acid receptors on respiratory epithelial cells and enters through receptor-mediated endocytosis. Viral replication within these cells causes cytopathic effects and triggers inflammatory responses that produce clinical respiratory signs. Damage to the respiratory epithelium impairs mucociliary clearance and compromises local immune defenses, predisposing to secondary bacterial colonization and pneumonia. Resolution occurs as the adaptive immune response clears viral infection and epithelial regeneration restores normal respiratory function, typically within seven to ten days of infection onset.

Early warning signs of swine influenza often develop remarkably rapidly, with clinical signs appearing in multiple animals nearly simultaneously within affected groups. Alert caretakers may notice a sudden reduction in feed consumption across an entire barn or room of pigs, often occurring overnight or within a single day. Subtle increases in coughing frequency may precede more obvious respiratory signs by hours to a day. Individual pigs appearing slightly lethargic or reluctant to rise when disturbed represent early indicators of developing illness. The explosive nature of influenza outbreaks, with rapid progression from few to many affected animals, helps distinguish this disease from more slowly spreading respiratory pathogens.

The hallmark clinical presentation of swine influenza is acute respiratory disease characterized by the sudden onset of fever, lethargy, anorexia, and respiratory distress across a large proportion of the exposed population. High fever ranging from 40.5 to 41.5 degrees Celsius (105 to 107 degrees Fahrenheit) occurs during the acute phase of infection. Affected pigs demonstrate pronounced depression and reluctance to move or rise when approached. Coughing begins as scattered dry coughs and progresses to frequent, often paroxysmal coughing affecting the majority of animals in affected groups. Labored breathing with increased respiratory rate and effort indicates lower respiratory tract involvement. Nasal discharge ranging from serous to mucopurulent develops in many affected animals.

Behavioral changes associated with swine influenza reflect the systemic illness produced by acute viral infection. Profound anorexia develops rapidly, with affected pigs showing complete disinterest in feed during the acute fever phase. Water consumption may be maintained or increased as pigs attempt to offset fluid losses from fever and respiratory secretions. Affected animals seek recumbency and show marked reluctance to stand or move when disturbed. Huddling behavior increases as febrile pigs alter thermoregulatory behavior. Social activity and normal exploratory behavior cease during acute illness. In breeding herds, boars may show reduced libido and reluctance to mate, while sows may show decreased nursing activity.

Physical examination findings in swine influenza cases correlate with disease stage and severity. Elevated rectal temperature during the acute phase confirms the febrile nature of illness. Respiratory auscultation may reveal increased bronchovesicular sounds, crackles, or wheezes depending on disease stage and secondary infection involvement. Nasal discharge and periocular staining from excessive lacrimation may be observed. Conjunctivitis with reddened, watery eyes occurs in some affected animals. Respiratory rate is increased, and dyspnea may be apparent in more severely affected individuals. Body condition typically shows minimal change during the brief acute illness, though weight loss occurs with prolonged anorexia in complicated cases.

Symptom progression in uncomplicated swine influenza follows a characteristic self-limiting course. Fever peaks within the first one to two days of illness and typically resolves by days three to four. Appetite recovery follows fever resolution, with feed consumption gradually returning toward normal over several days. Coughing may persist for one to two weeks after other clinical signs resolve as the respiratory epithelium regenerates. Complete clinical recovery in uncomplicated cases typically occurs within seven to ten days of onset. The rapid improvement characteristic of influenza, particularly the return of appetite and activity following fever resolution, helps distinguish this disease from other respiratory pathogens that produce more prolonged illness.

Emergency symptoms requiring immediate attention include severe respiratory distress with open-mouth breathing, cyanosis of extremities indicating inadequate oxygenation, and inability to rise or profound weakness. High mortality rates exceeding typical influenza expectations suggest secondary bacterial pneumonia or concurrent infection with more virulent pathogens. Sudden reproductive losses including abortion storms in breeding herds warrant urgent veterinary investigation. Individual animals showing signs of sepsis including mottled skin coloration, cold extremities, or collapse require immediate assessment. Any outbreak producing unexpectedly severe clinical signs or high mortality should prompt comprehensive diagnostic evaluation.

Clinical examination of suspected swine influenza cases focuses on recognizing the characteristic pattern of acute, rapidly spreading respiratory disease with self-limiting course. The explosive nature of outbreaks, affecting a large proportion of the herd within days, combined with fever, depression, coughing, and relatively rapid recovery, strongly suggests influenza. Physical examination confirms respiratory disease and assesses severity but cannot definitively distinguish influenza from other causes of acute respiratory illness. Gross necropsy findings in acute cases include pulmonary consolidation with cranioventral distribution, excessive bronchial exudate, and characteristic gross lesions of viral pneumonia, though laboratory confirmation remains essential for definitive diagnosis.

Laboratory diagnosis of swine influenza utilizes multiple methodologies for viral detection and characterization. Reverse transcriptase polymerase chain reaction (RT-PCR) testing of nasal swabs, bronchial alveolar lavage, or lung tissue provides sensitive and specific detection of influenza viral RNA. Matrix gene-targeted PCR identifies influenza A virus presence, while subtype-specific primers determine H and N classification. Virus isolation in embryonated chicken eggs or cell culture enables detailed strain characterization and is essential for vaccine strain selection. Sequencing of hemagglutinin and neuraminidase genes provides phylogenetic information valuable for epidemiological investigation and understanding strain evolution. Serological testing using hemagglutination inhibition or ELISA detects antibodies indicating exposure but cannot confirm active infection.

Differential diagnosis for acute respiratory disease in swine includes numerous other viral, bacterial, and environmental causes producing overlapping presentations. Porcine reproductive and respiratory syndrome causes respiratory disease that may be confused with influenza, though typically with more prolonged course and additional reproductive impacts. Mycoplasmal pneumonia produces chronic coughing but without the acute, explosive onset characteristic of influenza. Actinobacillus pleuropneumoniae causes severe pneumonia with high mortality that may initially resemble complicated influenza. Porcine circovirus-associated respiratory disease produces respiratory signs in the context of broader systemic illness. Environmental factors including poor ventilation, high ammonia levels, or dust exposure may contribute to respiratory signs mimicking infectious disease.

Herd-level diagnostic approaches help characterize influenza circulation patterns and guide vaccination program design. Systematic sampling of respiratory cases enables strain identification and monitoring of circulating variants over time. Serological profiling of different age groups reveals exposure patterns and identifies populations at risk. Oral fluid testing provides convenient population-level surveillance for influenza activity. Collaboration with diagnostic laboratories supports tracking of strain evolution and vaccine matching evaluation. Integration of diagnostic information with production records enables correlation of influenza activity with performance impacts. Ongoing surveillance programs detect new strain introductions and changes in endemic viral behavior.

Emergency and immediate treatment of swine influenza focuses on supportive care measures, as no approved antiviral medications are available for swine. Ensuring access to fresh, clean water supports hydration in febrile animals with increased fluid requirements. Reducing environmental stressors including temperature extremes, poor ventilation, and excessive noise supports recovery. Providing easily accessible feed encourages continued intake in animals with reduced appetite. Hospital pen housing for severely affected individuals reduces competition and allows closer monitoring. Environmental temperature management, typically maintaining temperatures at the lower end of the comfort zone, may provide relief for febrile animals.

Medical management of swine influenza centers on preventing and treating secondary bacterial infections that frequently complicate viral respiratory disease. Broad-spectrum antibiotics effective against common respiratory pathogens should be administered to animals showing signs of bacterial pneumonia, including persistent high fever, worsening respiratory distress, or failure to improve as expected. Injectable antibiotics provide reliable dosing in animals with reduced feed and water intake. Strategic mass medication through feed or water may be appropriate during acute outbreaks to prevent bacterial complications across affected groups. Anti-inflammatory medications including nonsteroidal anti-inflammatory drugs may provide symptomatic relief from fever and support appetite recovery. All pharmaceutical interventions must observe appropriate withdrawal times for market animals.

Surgical intervention plays no role in swine influenza treatment, as this condition requires medical management and supportive care rather than surgical correction. The self-limiting nature of uncomplicated influenza means that supportive measures alone enable recovery in most cases. Complications requiring more intensive intervention typically relate to secondary bacterial pneumonia rather than primary viral infection.

Supportive care beyond direct medical treatment encompasses environmental and management modifications that optimize recovery conditions. Reducing stocking density in affected barns decreases respiratory pathogen load and competition stress. Improving ventilation quality while maintaining appropriate temperatures balances air quality needs with thermal comfort for sick animals. Providing bedding materials encourages rest and reduces energy expenditure. Multiple water and feeding stations ensure sick animals can access resources without competition. Segregating severely affected animals for individual attention prevents suffering and reduces transmission to recovering penmates. Humane euthanasia of animals with poor prognosis prevents prolonged suffering.

Herd treatment protocols during influenza outbreaks combine individual animal care with population-level interventions. Strategic antibiotic use through water medication provides broad coverage against secondary bacterial pathogens across affected groups. Reviewing vaccination status and considering emergency vaccination may be appropriate, though vaccine protection typically requires two to four weeks to develop. Biosecurity measures limit spread to unaffected facilities while managing the outbreak within affected populations. Communication with veterinarians ensures appropriate diagnostic workup and intervention selection. Documentation of clinical signs, treatment responses, and outcomes supports future outbreak management.

Treatment decisions must balance animal welfare with practical and economic considerations. Most swine influenza cases recover with minimal intervention given the self-limiting nature of infection. Severe cases with respiratory distress or secondary pneumonia warrant more intensive treatment efforts. Animals failing to respond to appropriate treatment or showing signs of irreversible complications should be humanely euthanized. Economic analysis of treatment costs versus expected outcomes guides rational decision-making. Veterinary guidance assists producers in navigating treatment decisions while maintaining welfare standards.

Recovery timeline for uncomplicated swine influenza is characteristically rapid, distinguishing this disease from many other respiratory pathogens. Fever typically resolves within three to four days of onset, with appetite and activity returning shortly thereafter. Clinical respiratory signs including coughing may persist for one to two weeks as the damaged respiratory epithelium regenerates. Complete recovery of lung function and return to normal growth performance typically occurs within two to three weeks of infection onset. The rapid recovery characteristic of influenza allows affected groups to return to normal production with minimal long-term impact in most cases.

Post-treatment care and monitoring of recovered animals should continue through the convalescent period. Respiratory monitoring ensures progressive improvement and identifies animals developing secondary complications requiring additional treatment. Feed consumption tracking documents appetite recovery and identifies individuals with prolonged anorexia warranting evaluation. Growth performance monitoring reveals any lasting impacts of illness on production efficiency. Continued attention to secondary infection risk remains important during the recovery period when respiratory defenses are still compromised. Animals that fail to recover appropriately may warrant diagnostic investigation for concurrent pathogens or complications.

Prognostic factors influencing swine influenza recovery include infection severity, secondary pathogen involvement, underlying herd health status, and management response quality. Uncomplicated influenza affecting otherwise healthy pigs carries excellent prognosis with expected full recovery. Secondary bacterial pneumonia substantially worsens prognosis, potentially causing mortality and permanent lung damage in survivors. Concurrent infection with porcine reproductive and respiratory syndrome virus or other immunosuppressive pathogens prolongs illness and complicates recovery. Rapid implementation of supportive care and secondary infection control improves outcomes. Overall mortality in uncomplicated influenza outbreaks typically remains below two percent, though secondary complications can increase losses substantially.

Return to production considerations following influenza recovery focus on achieving appropriate growth performance and documenting any lasting impacts. Most pigs fully recover lost ground within a few weeks of clinical resolution, with compensatory growth offsetting acute illness losses. Evaluation of group performance compared to pre-illness baselines identifies any persistent effects. Breeding animals recovering from influenza typically return to normal reproductive function without lasting impairment. Recovered animals develop immunity to the infecting strain that provides partial protection against subsequent challenges, contributing to population immunity. Strategic decisions regarding vaccination program adjustment should consider the specific strains involved in outbreaks.

Vaccination represents the primary tool for swine influenza prevention, though the dynamic nature of influenza virus evolution creates ongoing challenges. Commercial influenza vaccines are available in most major swine-producing regions, containing inactivated virus strains representing currently circulating subtypes. Vaccine strain selection aims to match circulating field strains, though antigenic drift may reduce vaccine effectiveness over time as strains evolve. Both killed virus and modified live virus vaccine platforms are used depending on regional availability and specific product characteristics. Vaccination programs typically target breeding animals and growing pigs, with timing designed to protect during periods of greatest risk. Autogenous vaccines prepared from farm-specific viral isolates offer improved matching but require longer development timelines.

Biosecurity measures complement vaccination in comprehensive influenza control programs. Limiting introduction of infected animals through quarantine and health monitoring of incoming stock prevents new strain introductions. Transport vehicle sanitation reduces mechanical spread of virus between facilities. Personnel protocols including shower-in requirements, dedicated clothing, and restrictions on contact with other swine populations limit human-mediated transmission. Physical barriers and controlled entry points reduce introduction risk. Importantly, because swine influenza is zoonotic, biosecurity measures should protect both pigs from human influenza strains and farm workers from swine-adapted viruses, with particular attention during seasonal human influenza outbreaks.

Nutritional prevention strategies support immune function and respiratory health to optimize pig resistance to influenza challenge. Diets meeting or exceeding nutrient requirements provide substrate for optimal immune response. Vitamin E and selenium supplementation supports immunocompetence. Avoiding mycotoxin contamination prevents immunosuppressive toxin exposure. Water quality monitoring ensures this essential nutrient does not compromise animal health. Adequate nutrition during the peri-weaning period when influenza risk increases helps maintain immune function during this stressful transition.

Management practices significantly influence influenza transmission dynamics and should be optimized as part of control programs. All-in/all-out production flow with cleaning and disinfection between groups reduces viral persistence and allows disease breaks. Appropriate stocking densities reduce respiratory pathogen load and transmission pressure. Ventilation system design and operation must balance air quality with temperature control, providing adequate fresh air to dilute respiratory pathogens while maintaining thermal comfort. Avoiding mixing of pigs from multiple sources reduces introduction of novel strains and the potential for reassortment generating new variants. Gilt introduction programs should include influenza exposure and immunity development before breeding.

Quarantine and testing protocols help prevent introduction of novel influenza strains into established populations. Incoming breeding stock should undergo isolation periods with health monitoring before herd entry. Serological and virological testing during quarantine can identify active infection or recent exposure. Acclimation programs that deliberately expose incoming animals to resident viral strains under controlled conditions develop immunity before productive entry. Source verification ensures replacement animals come from herds with known health status. Coordination with veterinarians supports design of appropriate introduction protocols based on herd-specific circumstances.

Daily management and monitoring for swine influenza requires consistent observation protocols enabling early detection of respiratory disease outbreaks. Caretakers should observe all pigs during daily rounds, noting any increases in coughing frequency, changes in appetite, or alterations in activity level. Feed consumption monitoring at the group level provides early warning of developing health challenges, as sudden consumption drops often precede obvious clinical signs. Mortality recording and investigation ensures unusual death losses trigger diagnostic workup. Documentation of all observations enables trend analysis and supports veterinary consultation when respiratory disease activity increases.

Housing and environmental management significantly influence influenza transmission and clinical outcomes. Ventilation system design and operation must provide adequate fresh air exchange to dilute respiratory pathogens while maintaining appropriate temperature and humidity. Air filtration may provide additional protection in high-value populations. Appropriate stocking densities reduce transmission pressure and respiratory pathogen load. Temperature control within optimal ranges for each age group minimizes stress that compromises respiratory defenses. Regular maintenance ensures systems operate as designed. Attention to air quality factors including ammonia levels and dust concentrations supports respiratory health.

Herd health programs integrating influenza management with control of other respiratory pathogens optimize overall respiratory health. Vaccination schedules should coordinate influenza immunization with protection against other significant respiratory diseases including Mycoplasma hyopneumoniae and porcine reproductive and respiratory syndrome. Parasite control reduces additional immune system demands. Regular veterinary involvement ensures programs remain current and effective given the evolving nature of influenza epidemiology. Written protocols ensure consistent implementation across all personnel. Periodic program review incorporating diagnostic surveillance results enables adaptation to changing conditions.

Record keeping and monitoring systems provide essential data for influenza management and continuous improvement. Respiratory disease incidence tracking reveals outbreak patterns and evaluates intervention effectiveness. Mortality records distinguished by clinical presentation support accurate cause attribution. Treatment records document responses to interventions and guide protocol refinements. Vaccination records confirm program implementation and support correlation with disease outcomes. Diagnostic testing results maintained over time enable tracking of circulating strain evolution. Electronic systems facilitate data analysis and benchmarking against industry standards.

Economic considerations permeate influenza management decisions in commercial swine operations. Vaccination program costs must be weighed against expected reductions in disease losses and performance impacts. Autogenous vaccine development costs require evaluation against improved strain matching benefits. Treatment expenses during outbreaks factor into operational budgets. Production losses from mortality, reduced growth, and increased medication use affect profitability. Labor costs for managing sick animals and implementing control measures add to outbreak expenses. Comprehensive economic analysis supports rational decision-making balancing disease control investments with expected returns.

Swine influenza affects all domestic pig breeds without documented breed-specific resistance or susceptibility differences. The universal nature of influenza susceptibility in swine populations means that all genetic lines face similar disease risk when exposed to circulating viral strains. No breeding programs have successfully developed influenza-resistant lines, as the complexity of influenza immunity and the rapid evolution of viral strains make genetic selection approaches impractical. Individual variation in disease severity relates more to prior immunity status, concurrent health challenges, and management conditions than to genetic background. Producers cannot rely on breed selection as an influenza control strategy.

Production type influences influenza risk and management considerations though not fundamental disease susceptibility. Breeding herds must protect reproductive performance from influenza-associated losses including abortions and reduced fertility. High-health multiplier operations invest heavily in influenza prevention given the cascading consequences of breeding herd infection. Farrow-to-finish operations manage influenza risk across all production phases. Multi-site production systems face introduction risk at each pig movement point. Nursery operations receiving weaned pigs from external sources may experience influenza outbreaks when source herds have active circulation. Finishing operations with high animal turnover face ongoing introduction pressure.

Genetic selection and testing for influenza resistance do not represent practical options in current commercial swine production. The complexity of influenza immunity involving both humoral and cellular responses makes simple genetic selection challenging. The continuous evolution of influenza viruses through antigenic drift and reassortment would likely outpace genetic selection efforts even if effective markers were identified. No commercial genetic testing for influenza resistance is available. Producers should focus management efforts on vaccination, biosecurity, and environmental optimization rather than seeking genetic solutions to influenza control.

Swine influenza commonly co-occurs with other respiratory pathogens, creating complex disease syndromes with enhanced severity compared to single-agent infections. Porcine reproductive and respiratory syndrome virus frequently circulates alongside influenza, with combined infections producing more severe respiratory disease than either agent alone. Mycoplasma hyopneumoniae co-infection potentiates influenza-associated lung damage and predisposes to secondary bacterial complications. Bacterial pathogens including Pasteurella multocida, Streptococcus suis, Haemophilus parasuis, and Actinobacillus pleuropneumoniae commonly cause secondary infections following influenza-induced damage to respiratory defenses. Porcine circovirus type 2 contributes immunosuppression that worsens influenza outcomes. Comprehensive respiratory disease control requires attention to these multiple interacting pathogens.

Several conditions produce clinical presentations that may be confused with swine influenza, requiring careful diagnostic differentiation. Porcine reproductive and respiratory syndrome causes respiratory disease that may initially resemble influenza, though typically with more prolonged course and broader systemic involvement. Mycoplasmal pneumonia produces chronic coughing but without the acute, explosive onset and fever characteristic of influenza. Actinobacillus pleuropneumoniae causes severe acute pneumonia that may be mistaken for complicated influenza. Glasser's disease produces respiratory signs alongside polyserositis. Environmental factors including poor ventilation may produce respiratory symptoms mimicking infectious disease. Laboratory diagnosis enables accurate pathogen identification and appropriate management.

Complications and sequelae of swine influenza primarily relate to secondary bacterial pneumonia and its consequences. Uncomplicated influenza typically resolves completely without lasting effects. Secondary bacterial infections can cause chronic lung damage with persistent respiratory impairment. Severe pneumonia may result in abscessation or permanent lung consolidation. Systemic complications including septicemia can develop from bacterial superinfection. Reproductive losses including abortion may occur in breeding animals infected during pregnancy. Understanding potential complications informs monitoring strategies and intervention timing during influenza outbreaks.